Adial Pharmaceuticals, Inc. Other Notes Payable
Adial Pharmaceuticals, Inc. (ADIL) had Other Notes Payable of $29.09 thousand as of 2021-04-30, per its 10-K filed 2023-03-30.
Discontinued › Balance Sheet › Liabilities › Debt › Long-Term Debt, Unclassified › Notes and Loans Payable
us-gaap:OtherNotesPayable · last filed 2023-03-30
- 2021-04-30: Other Notes Payable $29.09K.
| Period end | Other Notes Payable |
|---|---|
| 2021-04-30 | $29.09K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |